MacroGenics
MGNX
$4.46
Share price
1.79%
Change (1 day)
-31.62%
Change (1 year)
Categories
P/S ratio for MacroGenics (MGNX)
P/S ratio as of May 2024 (TTM): 4.81
According to MacroGenics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.81488. At the end of 2023 the company had a P/S ratio of 10.5.
P/S ratio history for MacroGenics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.5 | 280.25% |
| 2022 | 2.76 | -78.67% |
| 2021 | 12.9 | -1.7% |
| 2020 | 13.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.75 | -42.78% | 🇺🇸 USA |
 Eli Lilly LLY | 20.0 | 316.23% | 🇺🇸 USA |
 Amgen AMGN | 5.87 | 21.91% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.10 | -35.55% | 🇺🇸 USA |
 Merck MRK | 5.45 | 13.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.01 | -58.34% | 🇺🇸 USA |
 Xencor XNCR | 7.82 | 62.35% | 🇺🇸 USA |